JP2020516232A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516232A5 JP2020516232A5 JP2019531917A JP2019531917A JP2020516232A5 JP 2020516232 A5 JP2020516232 A5 JP 2020516232A5 JP 2019531917 A JP2019531917 A JP 2019531917A JP 2019531917 A JP2019531917 A JP 2019531917A JP 2020516232 A5 JP2020516232 A5 JP 2020516232A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- detection
- nucleic acid
- overhang
- label
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 claims description 136
- 108020004707 nucleic acids Proteins 0.000 claims description 124
- 102000039446 nucleic acids Human genes 0.000 claims description 124
- 150000007523 nucleic acids Chemical class 0.000 claims description 124
- 238000000034 method Methods 0.000 claims description 95
- 239000000203 mixture Substances 0.000 claims description 89
- 230000000295 complement effect Effects 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 21
- 102000004169 proteins and genes Human genes 0.000 claims description 21
- 238000009396 hybridization Methods 0.000 claims description 15
- 239000002773 nucleotide Substances 0.000 claims description 15
- 125000003729 nucleotide group Chemical group 0.000 claims description 15
- 230000000692 anti-sense effect Effects 0.000 claims description 13
- 239000003446 ligand Substances 0.000 claims description 11
- 102000018697 Membrane Proteins Human genes 0.000 claims 1
- 108010052285 Membrane Proteins Proteins 0.000 claims 1
- 230000001351 cycling effect Effects 0.000 claims 1
- 238000003556 assay Methods 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 14
- 239000007894 caplet Substances 0.000 description 13
- 238000010362 genome editing Methods 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 102000004506 Blood Proteins Human genes 0.000 description 6
- 108010017384 Blood Proteins Proteins 0.000 description 6
- 108091033409 CRISPR Proteins 0.000 description 6
- 102000014914 Carrier Proteins Human genes 0.000 description 6
- 108010078791 Carrier Proteins Proteins 0.000 description 6
- 101710163270 Nuclease Proteins 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 102000012410 DNA Ligases Human genes 0.000 description 5
- 108010061982 DNA Ligases Proteins 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 4
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 4
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 4
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- HLXHCNWEVQNNKA-UHFFFAOYSA-N 5-methoxy-2,3-dihydro-1h-inden-2-amine Chemical compound COC1=CC=C2CC(N)CC2=C1 HLXHCNWEVQNNKA-UHFFFAOYSA-N 0.000 description 3
- 101710159080 Aconitate hydratase A Proteins 0.000 description 3
- 101710159078 Aconitate hydratase B Proteins 0.000 description 3
- 102000011767 Acute-Phase Proteins Human genes 0.000 description 3
- 108010062271 Acute-Phase Proteins Proteins 0.000 description 3
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 3
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 3
- 238000010354 CRISPR gene editing Methods 0.000 description 3
- 101000709520 Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) Atypical response regulator protein ChxR Proteins 0.000 description 3
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 3
- 101710096438 DNA-binding protein Proteins 0.000 description 3
- 102100021238 Dynamin-2 Human genes 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 101000817607 Homo sapiens Dynamin-2 Proteins 0.000 description 3
- 102000004310 Ion Channels Human genes 0.000 description 3
- 102000044126 RNA-Binding Proteins Human genes 0.000 description 3
- 101710105008 RNA-binding protein Proteins 0.000 description 3
- 102000039471 Small Nuclear RNA Human genes 0.000 description 3
- 108020004688 Small Nuclear RNA Proteins 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 230000002337 anti-port Effects 0.000 description 3
- 239000003114 blood coagulation factor Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000021164 cell adhesion Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 108091027963 non-coding RNA Proteins 0.000 description 3
- 102000042567 non-coding RNA Human genes 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000002096 quantum dot Substances 0.000 description 3
- -1 rRNA Proteins 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 230000032895 transmembrane transport Effects 0.000 description 3
- 239000004971 Cross linker Substances 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 208000014644 Brain disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022020366A JP2022058977A (ja) | 2016-12-16 | 2022-02-14 | ライゲーション増幅を使用する分子検出 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662435424P | 2016-12-16 | 2016-12-16 | |
| US62/435,424 | 2016-12-16 | ||
| US201762480107P | 2017-03-31 | 2017-03-31 | |
| US62/480,107 | 2017-03-31 | ||
| US201762509995P | 2017-05-23 | 2017-05-23 | |
| US62/509,995 | 2017-05-23 | ||
| PCT/US2017/066841 WO2018112422A1 (en) | 2016-12-16 | 2017-12-15 | Molecular detection using ligation amplification |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022020366A Division JP2022058977A (ja) | 2016-12-16 | 2022-02-14 | ライゲーション増幅を使用する分子検出 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516232A JP2020516232A (ja) | 2020-06-11 |
| JP2020516232A5 true JP2020516232A5 (OSRAM) | 2021-01-28 |
| JP7093355B2 JP7093355B2 (ja) | 2022-06-29 |
Family
ID=62559496
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531917A Active JP7093355B2 (ja) | 2016-12-16 | 2017-12-15 | ライゲーション増幅を使用する分子検出 |
| JP2022020366A Pending JP2022058977A (ja) | 2016-12-16 | 2022-02-14 | ライゲーション増幅を使用する分子検出 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022020366A Pending JP2022058977A (ja) | 2016-12-16 | 2022-02-14 | ライゲーション増幅を使用する分子検出 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10781477B2 (OSRAM) |
| EP (3) | EP3555313B1 (OSRAM) |
| JP (2) | JP7093355B2 (OSRAM) |
| CN (2) | CN110300806B (OSRAM) |
| CA (1) | CA3047127A1 (OSRAM) |
| DK (2) | DK3555313T3 (OSRAM) |
| FI (1) | FI3929304T3 (OSRAM) |
| WO (1) | WO2018112422A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110300806B (zh) * | 2016-12-16 | 2024-03-19 | 艾瑞特姆有限责任公司 | 使用连接扩增的分子检测 |
| SG11202108618VA (en) * | 2019-02-15 | 2021-09-29 | Advanced Cell Diagnostics Inc | Methods for multiplex detection of nucleic acids by in situ hybridization |
| US11076219B2 (en) * | 2019-04-12 | 2021-07-27 | Bose Corporation | Automated control of noise reduction or noise masking |
| US20240167081A1 (en) * | 2022-11-08 | 2024-05-23 | 10X Genomics,Inc. | Immobilization methods and compositions for in situ detection |
| EP4653542A1 (en) * | 2024-05-21 | 2025-11-26 | Leica Microsystems CMS GmbH | Label, marker and method for analysing a biological sample |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US317077A (en) * | 1885-05-05 | belcher | ||
| CA2039517C (en) * | 1990-04-03 | 2006-11-07 | David Segev | Dna probe signal amplification |
| US6011020A (en) * | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| US5386020A (en) * | 1991-01-10 | 1995-01-31 | New York University | Multiply connected, three-dimensional nucleic acid structures |
| US5681697A (en) * | 1993-12-08 | 1997-10-28 | Chiron Corporation | Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor |
| US5854033A (en) * | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| US6072044A (en) * | 1996-04-26 | 2000-06-06 | New York University | Nanoconstructions of geometrical objects and lattices from antiparallel nucleic acid double crossover molecules |
| WO1998002580A2 (en) * | 1996-07-12 | 1998-01-22 | Tm Technologies, Inc. | Signal amplification method |
| US6261771B1 (en) * | 1998-02-18 | 2001-07-17 | The United States Of America As Represented By The Secretary Of The Army | Method and apparatus for detection of multiple nucleic acid sequences and multiple antigens |
| US6403309B1 (en) * | 1999-03-19 | 2002-06-11 | Valigen (Us), Inc. | Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays |
| JP2001013139A (ja) | 1999-06-28 | 2001-01-19 | Toyobo Co Ltd | 免疫学的測定法 |
| US6686461B1 (en) * | 2000-03-22 | 2004-02-03 | Solulink Bioscience, Inc. | Triphosphate oligonucleotide modification reagents and uses thereof |
| ATE364722T1 (de) * | 2000-06-02 | 2007-07-15 | Bayer Corp | Verfahren zum nachweis und zur lokalisierung von genen in situ durch hybridisierung einer verzweigten dna |
| US6531283B1 (en) | 2000-06-20 | 2003-03-11 | Molecular Staging, Inc. | Protein expression profiling |
| DE10201886B4 (de) * | 2001-01-19 | 2014-01-23 | Honda Giken Kogyo K.K. | Polymerelektrolytmembran sowie Verfahren zur Herstellung dieser und Festpolymerelektrolytbrennstoffzelle, welche diese verwendet |
| WO2002068695A2 (en) | 2001-02-22 | 2002-09-06 | Arcturus Engineering, Inc. | Quantitative immunohistochemistry (qihc) |
| US20030082584A1 (en) * | 2001-06-29 | 2003-05-01 | Liang Shi | Enzymatic ligation-based identification of transcript expression |
| WO2003031591A2 (en) | 2001-10-10 | 2003-04-17 | Superarray Bioscience Corporation | Detecting targets by unique identifier nucleotide tags |
| CA2363703A1 (en) * | 2001-11-23 | 2003-05-23 | Royce Technologies Llc, A Nevada Corporation | Method for amplification of molecular bio-assay signals |
| WO2005010494A2 (en) | 2003-07-21 | 2005-02-03 | Jie Wu | Multiplexed analyte detection |
| US7727721B2 (en) * | 2005-03-08 | 2010-06-01 | California Institute Of Technology | Hybridization chain reaction amplification for in situ imaging |
| US8241874B2 (en) * | 2005-05-04 | 2012-08-14 | Wayne State University | Rolling circle amplification |
| US20070048759A1 (en) * | 2005-06-10 | 2007-03-01 | Dan Luo | Detection of target molecules with labeled nucleic acid detection molecules |
| CN101495650B (zh) | 2005-06-20 | 2015-02-04 | 领先细胞医疗诊断有限公司 | 检测单个细胞中的核酸和鉴定异质大细胞群中罕见细胞的方法 |
| US8741566B2 (en) | 2005-07-01 | 2014-06-03 | Dako Denmark A/S | Immunohistochemistry and in situ hybridization detection method |
| AU2006330830B2 (en) * | 2005-12-23 | 2013-01-10 | Bruker Spatial Biology, Inc. | Nanoreporters and methods of manufacturing and use thereof |
| WO2008027452A2 (en) * | 2006-08-29 | 2008-03-06 | R. Crea And Company | Self-assembling oligonucleotides and methods |
| DK3564674T3 (da) * | 2006-11-01 | 2021-10-18 | Ventana Med Syst Inc | Haptener, haptenkonjugater, sammensætninger deraf og fremgangsmåde til fremstilling og anvendelse deraf |
| US8309306B2 (en) * | 2008-11-12 | 2012-11-13 | Nodality, Inc. | Detection composition |
| EP2189539B2 (en) * | 2008-11-21 | 2018-06-13 | Chimera Biotec GmbH | Conjugate complexes for analyte detection |
| ES2606012T3 (es) * | 2010-02-26 | 2017-03-17 | Ventana Medical Systems, Inc. | Hibridación in situ con sondas PolyTag |
| US9512471B2 (en) * | 2010-06-30 | 2016-12-06 | Diacarta Inc | Methods and kits for detecting human papillomavirus |
| ES2562821T3 (es) | 2010-10-21 | 2016-03-08 | Advanced Cell Diagnostics, Inc. | Método ultrasensible para la detección in situ de ácidos nucleicos |
| US9556473B2 (en) * | 2011-02-15 | 2017-01-31 | Leica Biosystems Newcastle Ltd | Methods for identifying nucleic acid sequences |
| US8946389B2 (en) | 2011-04-25 | 2015-02-03 | University Of Washington | Compositions and methods for multiplex biomarker profiling |
| GB201108678D0 (en) * | 2011-05-24 | 2011-07-06 | Olink Ab | Multiplexed proximity ligation assay |
| US9651549B2 (en) * | 2012-07-13 | 2017-05-16 | Genisphere, Llc | Lateral flow assays using DNA dendrimers |
| GB201218909D0 (en) | 2012-10-22 | 2012-12-05 | Univ Singapore | Assay for the parallel detection of biological material based on PCR |
| WO2014145620A2 (en) * | 2013-03-15 | 2014-09-18 | The Broad Institute, Inc. | Novel hybridization probes and uses thereof |
| CA2919833A1 (en) * | 2013-07-30 | 2015-02-05 | President And Fellows Of Harvard College | Quantitative dna-based imaging and super-resolution imaging |
| DE102014001685A1 (de) * | 2014-02-07 | 2015-08-13 | Kiekert Aktiengesellschaft | Kraftfahrzeugschloss mit integrierter Zuziehhilfe |
| US9909167B2 (en) | 2014-06-23 | 2018-03-06 | The Board Of Trustees Of The Leland Stanford Junior University | On-slide staining by primer extension |
| WO2016057842A2 (en) * | 2014-10-08 | 2016-04-14 | Aratome, LLC | High resolution imaging of tissue proteins |
| US11078528B2 (en) | 2015-10-12 | 2021-08-03 | Advanced Cell Diagnostics, Inc. | In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto |
| CN105353131B (zh) * | 2015-10-23 | 2017-04-19 | 山东大学 | 基于双编码和单分子计数的细胞因子多重检测方法 |
| MX2018013341A (es) * | 2016-05-02 | 2019-09-18 | Encodia Inc | Analisis de macromoleculas que emplea la codificacion de acido nucleico. |
| DK3481843T3 (en) * | 2016-07-05 | 2022-02-07 | California Inst Of Techn | Fractional initiator hybridization chain reaction |
| SG11201901733PA (en) * | 2016-09-26 | 2019-04-29 | Cellular Res Inc | Measurement of protein expression using reagents with barcoded oligonucleotide sequences |
| CN110300806B (zh) * | 2016-12-16 | 2024-03-19 | 艾瑞特姆有限责任公司 | 使用连接扩增的分子检测 |
-
2017
- 2017-12-15 CN CN201780086781.2A patent/CN110300806B/zh active Active
- 2017-12-15 WO PCT/US2017/066841 patent/WO2018112422A1/en not_active Ceased
- 2017-12-15 FI FIEP21177377.5T patent/FI3929304T3/fi active
- 2017-12-15 DK DK17881278.0T patent/DK3555313T3/da active
- 2017-12-15 CA CA3047127A patent/CA3047127A1/en active Pending
- 2017-12-15 DK DK21177377.5T patent/DK3929304T3/da active
- 2017-12-15 EP EP17881278.0A patent/EP3555313B1/en active Active
- 2017-12-15 EP EP21177377.5A patent/EP3929304B1/en active Active
- 2017-12-15 CN CN202410215614.5A patent/CN118086461A/zh active Pending
- 2017-12-15 JP JP2019531917A patent/JP7093355B2/ja active Active
- 2017-12-15 EP EP23190368.3A patent/EP4328323A3/en active Pending
-
2019
- 2019-01-23 US US16/254,926 patent/US10781477B2/en active Active
-
2020
- 2020-07-27 US US16/939,921 patent/US20200377933A1/en active Pending
-
2022
- 2022-02-14 JP JP2022020366A patent/JP2022058977A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516232A5 (OSRAM) | ||
| JP5872569B2 (ja) | マイクロアレイに基づくアッセイのための粒子と結合させた発光団で標識された分子 | |
| EP2920324B1 (en) | Localised rca-based amplification method | |
| EP2707502B1 (en) | Unfolding proximity probes and methods for the use thereof | |
| US11352658B2 (en) | Method for selecting a target nucleic acid sequence | |
| EP2920320B1 (en) | Rca reporter probes and their use in detecting nucleic acid molecules | |
| EP3174997B1 (en) | Method for selecting a target nucleic acid sequence | |
| US20180119211A1 (en) | Method for Detecting Target Nucleic Acid | |
| US10590474B2 (en) | Methods for true isothermal strand displacement amplification | |
| WO2017008177A1 (en) | Compositions and methods for detection of genetic deafness gene mutation | |
| JP2015156872A5 (OSRAM) | ||
| JP6937294B2 (ja) | ゲノムターゲットエンリッチメント及び選択的ｄｎａシーケンシングのための方法及び組成物 | |
| US20230175047A1 (en) | Array and method for detecting spatial information of nucleic acids | |
| KR20150028063A (ko) | 리포터 및 소광자가 결합된 프로브를 이용한 액상형 어레이 및 이를 이용한 표적핵산 또는 돌연변이 검출방법 | |
| CN103717752B (zh) | 核酸分析法 | |
| JP2002509694A5 (OSRAM) | ||
| JPWO2001075157A1 (ja) | プローブポリマー作製用プローブ、プローブポリマーの作製方法及びその利用 | |
| EP1721991B1 (en) | Method of detecting nucleic acid and utilization thereof | |
| Kristoffersen et al. | Interlinked DNA nano-circles for measuring topoisomerase II activity at the level of single decatenation events | |
| US8945883B2 (en) | In situ cloning from pathological tissue specimens | |
| Smolina et al. | PNA openers and their applications for bacterial DNA diagnostics | |
| CA2564838A1 (en) | Hybridization method | |
| JP2003511660A (ja) | 電気化学ルミネセンスヘリカーゼアッセイ | |
| Yan et al. | LNA-modified isothermal oligonucleotide microarray for differentiating bacilli of similar origin | |
| CA2379749A1 (en) | Multiplexed strand displacement for nucleic acid determinations |